| Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta L Cerveny, Z Ptackova, M Ceckova, R Karahoda, S Karbanova, ... Drug Metabolism and Disposition 46 (11), 1817-1826, 2018 | 37 | 2018 |
| Expression of Concentrative Nucleoside Transporters (SLC28A) in the Human Placenta: Effects of Gestation Age and Prototype Differentiation-Affecting Agents L Jiraskova, L Cerveny, S Karbanova, Z Ptackova, F Staud Molecular pharmaceutics 15 (7), 2732-2741, 2018 | 21 | 2018 |
| Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters S Karbanova, L Cerveny, L Jiraskova, R Karahoda, M Ceckova, ... Biochemical Pharmacology 163, 60-70, 2019 | 19 | 2019 |
| Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine S Karbanova, L Cerveny, M Ceckova, Z Ptackova, L Jiraskova, ... Placenta 60, 86-92, 2017 | 16 | 2017 |
| Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal … L Cerveny, Z Neumanova, S Karbanova, I Havlova, F Staud Journal of Pharmacy and Pharmacology 68 (1), 84-92, 2016 | 10 | 2016 |
| S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is not a selective inhibitor of equilibrative nucleoside transporters but also blocks efflux activity of breast cancer resistance protein S Karbanova, A Sorf, L Jiraskova, A Lalinska, Z Ptackova, F Staud, ... Pharmaceutical Research 37, 1-9, 2020 | 7 | 2020 |
| Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of … L Cerveny, S Karbanova, R Karahoda, H Horackova, L Jiraskova, ... Toxicology and Applied Pharmacology 463, 116427, 2023 | 1 | 2023 |
| Equilibrative nucleoside transporter 1 (ENT1) facilitates transfer of the antiretroviral drug abacavir across the placenta L Cerveny, Z Ptackova, M Ceckova, L Jiraskova, S Karbanova, ... Drug Metabolism and Pharmacokinetics 34 (1), S71-S72, 2019 | 1 | 2019 |
| Studium interakcí antivirotik s vybranými placentárními transportéry S Karbanová Univerzita Karlova, Farmaceutická fakulta v Hradci Králové, 2020 | | 2020 |
| The role of nucleoside transporters in entecavir transport across placenta S Karbanova, L Cerveny, F Staud Drug Metabolism and Pharmacokinetics 34 (1), S40, 2019 | | 2019 |
| Expression of concentrative nucleoside transporters (SLC28A) in the human placenta; effects of gestation age and prototype differentiation-affecting agents L Jiraskova, S Karbanova, Z Ptackova, F Staud Drug Metabolism and Pharmacokinetics 34 (1), S73, 2019 | | 2019 |
| EXPRESSION AND FUNCTION OF NUCLEOSIDE TRANSPORTERS IN THE PLACENTA; ROLE IN MATERNO-FETAL DISPOSITION OF NUCLEOSIDE-DERIVED ANTIVIRALS L Cerveny, Z Ptackova, S Karbanova, L Jiraskova, R Karahoda, ... PLACENTA 69, E46-E46, 2018 | | 2018 |
Frantisek StaudProfessor of pharmacology, Charles University, Faculty of PharmacyE-mailová adresa ověřena na: faf.cuni.cz
